Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry studyDavid J. Pinato, David García-Illescas, Josep Tabernero et al.|The Lancet Oncology|2021Cited by 136
Time-Dependent COVID-19 Mortality in Patients With CancerOnCovid study group, Ariadna Roqué, David J. Pinato et al.|JAMA Oncology|2021Cited by 72
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European studyDavid J. Pinato, Yien Ning Sophia Wong, David García-Illescas et al.|European Journal of Cancer|2021Cited by 51
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registryLaia Garrigós, Maria Belen Delany, Nikolaos Diamantis et al.|Therapeutic Advances in Medical Oncology|2021Cited by 7